Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 9, 2007

Primary Completion Date

June 25, 2015

Study Completion Date

June 25, 2015

Conditions
Complete Hydatidiform MoleNon-Metastatic Gestational Trophoblastic TumorPartial Hydatidiform Mole
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Therapeutic Conventional Surgery

Undergo second curettage

Trial Locations (29)

11203

State University of New York Downstate Medical Center, Brooklyn

19001

Abington Memorial Hospital, Abington

24016

Carilion Clinic Gynecological Oncology, Roanoke

27834

Gynecologic Oncology Network, Greenville

31404

Memorial University Medical Center, Savannah

43210

Ohio State University Comprehensive Cancer Center, Columbus

45219

University of Cincinnati/Barrett Cancer Center, Cincinnati

49001

Borgess Medical Center, Kalamazoo

49007

Bronson Methodist Hospital, Kalamazoo

West Michigan Cancer Center, Kalamazoo

60611

Northwestern University, Chicago

73104

University of Oklahoma Health Sciences Center, Oklahoma City

74146

Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa

75235

Parkland Memorial Hospital, Dallas

75390

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

80010

Colorado Gynecologic Oncology Group, Aurora

80045

University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora

87102

University of New Mexico Cancer Center, Albuquerque

89169

Women's Cancer Center of Nevada, Las Vegas

91342

Olive View-University of California Los Angeles Medical Center, Sylmar

94040

Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View

94115

UCSF Medical Center-Mount Zion, San Francisco

94304

Stanford Cancer Institute, Palo Alto

06102

Hartford Hospital, Hartford

06050

The Hospital of Central Connecticut, New Britain

08060

Virtua Memorial, Mount Holly

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

08043

Virtua Voorhees, Voorhees Township

M4N 3M5

Odette Cancer Centre- Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00521118 - Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors | Biotech Hunter | Biotech Hunter